Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 8-K Event Results of operations
  2. 8-K Event Executive or director change
  3. 8-K Event Executive or director change
  4. 8-K Event Delisting notice
  5. 4 Grant or award Director acquired 21,649 shares (grant or award)
  6. 4 Grant or award Director acquired 18,753 shares (grant or award)
  7. 4 Grant or award Director acquired 18,295 shares (grant or award)
  8. 4 Grant or award Director acquired 21,802 shares (grant or award)
  9. 8-K Event Delisting notice
  10. EFFECT Other Notice of Effectiveness
  11. 424B3 Offering Prospectus
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Shareholder vote results
  19. 4 Grant or award Director acquired 15,454 shares (grant or award)
  20. 4 Grant or award Director acquired 17,841 shares (grant or award)

Page 6 of 14 · 267 filings